Essential industry resource for CIOs and IT leaders names eClinical Solutions as a Sample Vendor in three categories
BOSTON–(BUSINESS WIRE)–eClinical Solutions, a global provider of digital clinical software and services, today announced it has been named as a 2022 Gartner® Hype Cycle for Life Science Clinical Development Sample Vendor in three categories including Clinical Data Analytics Platforms, Risk-Based and Centralized Monitoring, and Clinical Trial Resource Management. Gartner Hype Cycles provide a graphic representation of the maturity and adoption of technologies and applications, and how they are potentially relevant to solving real business problems and exploiting new opportunities.
According to Gartner, “This Hype Cycle explores innovative technologies that are specifically relevant to life science clinical development programs in the pharmaceutical, biotechnology, diagnostics, medical device, research institution and contract research sectors.” Further mentioning to, “Use the information in this Hype Cycle to identify technologies that have the potential to deliver the value CIOs, IT leaders and business professionals in life sciences demand while evaluating the risks associated with those innovations.”
According to Gartner, “clinical data analytics platforms bring modern data and analytics approaches to clinical trial data processes, expanding on existing clinical data repository solutions and data science laboratories by integrating them under a modern logical data warehouse architecture.” Furthermore, Gartner reports that in today’s life science market “the current lack of data and analytics technology and process maturity makes clinical data analytics platforms important. These solutions can harmonize the intake of data from the myriad of clinical trial sources and present data from separate systems as a single source. With the upward trend of more complex trial types, these solutions assist in eliminating data silos, supporting trial builds, normalizing metadata and enabling integrated insights generation during trial conduct.”
eClinical Solutions was also recognized in the risk-based and centralized monitoring (RBM) category, also known as risk-based quality management (RBQM). Gartner states that “by centralizing trial data and using RBM techniques, monitoring activities performed during on-site visits, such as source data verification (SDV), can be optimized.” Further mentioning that, “RBM improves site monitoring over the legacy practice where quality checks are performed on 100% of the data during trials.” And continues to mention, “Well-executed RBM practices reduce the likelihood of errors created during clinical trials, improve overall safety of trial subjects and give greater visibility into clinical trial operations, which can accelerate timelines and improve overall quality.”
In the third category where eClinical Solutions was named a Sample Vendor, Gartner defines clinical trial resource management systems as “the technology capabilities used to manage the resources of a clinical trial, such as investigative sites, contract research organizations (CROs), clinical study staff, supplies, relationships and patients.” Gartner also reports that “sophisticated clinical trial resource management is essential to ensuring the efficient use of resources, management of relationships and closure on financial compensation to participating clinical research organizations (CROs), investigative sites and patients.”
“eClinical Solutions is extremely proud of our Gartner recognition across all three categories in which we were included in this Hype Cycle report,” said Raj Indupuri, CEO, eClinical Solutions. “2022 marks our 10-year anniversary and throughout our decade serving the life science industry we have consistently innovated our elluminate Clinical Data Cloud platform to meet and exceed customer needs. We remain focused on delivering the most modern clinical trial technology and service capabilities that drive significant operational efficiencies and meaningful financial results for our clients.”
As the foundation for digital trials, elluminate provides a central location for all clinical and operational data, creating a single source of truth across all data sources from ingestion to insights. The platform’s out of the box data connectors, built-in automation, advanced analytics, and self-service access to data from a single location allow value to be recognized faster and enable smarter decision-making throughout the trial lifecycle for top 20, mid-size, and emerging life science companies.
This latest recognition follows eClinical Solutions being named as a Representative Vendor for E-Clinical Platforms in the April 2022 Gartner Market Guide for Life Science E-Clinical Platforms report, by Jeff Smith, Sr. Director Analyst.
For more information about eClinical Solutions’ inclusion in the 2022 Gartner Hype Cycle and to download a full copy of the report, please click here.
Gartner does not endorse any vendor, product or service depicted in our research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
GARTNER and HYPE CYCLE are registered trademarks and service marks of Gartner, Inc. and/or its affiliates in the U.S. and internationally, and is used herein with permission. All rights reserved.
About eClinical Solutions
eClinical Solutions helps life sciences organizations around the world accelerate clinical development initiatives with expert data services and the elluminate Clinical Data Cloud – the foundation of digital trials. Together, the elluminate platform and digital data services give clients self-service access to all their data from one centralized location plus advanced analytics that help them make smarter, faster business decisions. Find out more at eclinicalsol.com.